Zhejiang Ausun Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Accelerating Development of APIs & Chemical Intermediates through innovation.
One of their notable products is RAMELTEON, with a corresponding US DMF Number 33719.
Remarkably, this DMF maintains an Active status since its submission on August 31, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 22, 2019, and payment made on August 16, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II